<DOC>
	<DOCNO>NCT02838043</DOCNO>
	<brief_summary>This study 8-week open-label pilot study examine subjective objective change mood , anxiety , cognition , sleep introduction probiotic supplement contain Lactobacillus helveticus Bifidobacterium longum 10 treatment-naïve participant diagnose major depressive disorder ( MDD ) . In order examine full composition micro biome , investigator also collect analyze fecal sample well blood sample examine change plasma level inflammatory marker , 5-HT , tryptophan order look possible underlying mechanism change see .</brief_summary>
	<brief_title>The Efficacy , Safety , Tolerability Probiotics Mood Cognition Depressed Patients</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . Diagnosis Major Depressive Disorder ( MDD ) Mini International Neuropsychiatric Interview ( MINI ) 2 . Current depressive episode MADRS score ≥ 20 3 . Males female age 18 65 4 . Able understand comply requirement study 5 . Provision write informed consent 1 . Use antidepressant drug 2 . Use antibiotic drug past 4 week ( may eligible participate 1month washout period ) 3 . Use sleep medication past 4 week ( may eligible participate 1month washout period ) 4 . Milk , yeast , soy allergy 5 . History alcohol substance abuse past 6 month 6 . Daily use probiotic product past 2 week ( may eligible participate 2week washout period ) 7 . Use type laxative 8 . Consumption product fortify probiotic 9 . Severely suicidal 10 . Experiencing psychosis bipolar episode 11 . History epilepsy uncontrolled seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>